Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ping An Biomedical (PASW) Accounts Payables (2024 - 2025)

Ping An Biomedical posted quarterly Accounts Payables of $1.3 million for Q3 2025, up 1450.46% year-on-year from $84827.7 in Q3 2024, and up 1450.46% on a QoQ basis from $84827.7 in Q3 2024.

Ping An Biomedical (PASW) has 2 years of Accounts Payables data on file, last reported at $1.3 million in Q3 2025.

  • For the quarter ending Q3 2025, Accounts Payables rose 1450.46% year-over-year to $1.3 million; the trailing twelve-month figure through Sep 2025 stood at $1.3 million (up 1450.46% YoY), and the FY2025 full-year result was $40409.0, down 52.36% from the prior year.
  • Accounts Payables for Q3 2025 stood at $1.3 million, up from $84827.7 in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.3 million in Q3 2025 and bottomed at $84827.7 in Q3 2024.

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 1.32 Mn
Sep 30, 2024 84,827.72